A New Approach of <i>In Vivo</i> Musculoskeletal Tissue Engineering Using the Epigastric Artery as Central Core Vessel of a 3-Dimensional Construct

<table>Bioluminescence followup after myoblasts implantation including the epigastric artery as central-core vessel (perfused BAT): (a) day of surgery, (b) 1 day after implantation, (c) 7 days after implantation, (d) 7 days after implantation of myoblasts without central-core vessel in 3D-construct (unperfused BAT).</table>

Plastic Surgery International

fig4

Figure 4

Figure 4: A New Approach of <i>In Vivo</i> Musculoskeletal Tissue Engineering Using the Epigastric Artery as Central Core Vessel of a 3-Dimensional Construct 

Figure 4 | A New Approach of In Vivo Musculoskeletal Tissue Engineering Using the Epigastric Artery as Central Core Vessel of a 3-Dimensional Construct 